Cellcept and Starlix drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cellcept (mycophenolate mofetil) and Starlix (nateglinide). Common drug interactions include back pain among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Cellcept and Starlix. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Cellcept?

Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.

What is Starlix?

Starlix has active ingredients of nateglinide. It is often used in diabetes. eHealthMe is studying from 3,768 Starlix users. Check the latest studies of Starlix.

On Jul, 15, 2026

32 people who take Cellcept and Starlix together, and have interactions are studied.

What are the common drug interactions of Cellcept and Starlix, by gender? *:

female:

Back pain
Bone pain
Hospitalisation
Aplasia pure red cell (type of anaemia affecting the precursors to red blood cells but not to white blood cells)
Malaise (a feeling of general discomfort or uneasiness)
Weight decreased
Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Anaemia (lack of blood)
Anal atresia (anus is either not present or it is in the wrong place)
Appetite disorder (abnormal eating habits)

male:

Pyrexia (fever)
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Muscular weakness (muscle weakness)
Pain
Renal failure chronic (long lasting kidney dysfunction)
Death
Fall
Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
Chills (felling of cold)
Red blood cell count decreased

What are the common drug interactions of Cellcept and Starlix, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Influenza
Pneumonia klebsiella (pneumonia caused by bacteria klebsiella)

50-59:

Back pain
Bone pain
Hospitalisation
Weight decreased
Appetite disorder (abnormal eating habits)
Blood glucose increased
Headache (pain in head)
Malaise (a feeling of general discomfort or uneasiness)
Nausea (feeling of having an urge to vomit)
Tooth infection

60+:

Pyrexia (fever)
Cardiac failure congestive
Malaise (a feeling of general discomfort or uneasiness)
Transplant rejection (a transplant material is not worked)
Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
Anaemia (lack of blood)
Respiratory failure (inadequate gas exchange by the respiratory system)
Chills (felling of cold)
Diarrhoea
Red blood cell count decreased

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 6 people, 18.75%
Chronic Renal Failure (kidney failure): 6 people, 18.75%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 4 people, 12.50%
Renal Artery Stenosis (narrowing of renal artery): 3 people, 9.38%
Nuclear Magnetic Resonance Imaging Brain: 3 people, 9.38%
Nuclear Magnetic Resonance Imaging Abdominal: 3 people, 9.38%
Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 3 people, 9.38%
Cardiac Failure Congestive: 3 people, 9.38%
Pain: 2 people, 6.25%
Hyperglycemia (high blood sugar): 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Cellcept and Starlix?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously